Inspira Technologies Oxy B.H.N. Ltd. (IINN)
NASDAQ: IINN · Real-Time Price · USD
0.4249
+0.0179 (4.40%)
At close: Apr 10, 2026, 4:00 PM EDT
0.4263
+0.0014 (0.33%)
After-hours: Apr 10, 2026, 7:26 PM EDT
Company Description
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.
It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats.
The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N.
Ltd. in July 2020. Inspira Technologies Oxy B.H.N.
Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Inspira Technologies Oxy B.H.N. Ltd.
| Country | Israel |
| Founded | 2018 |
| IPO Date | Jul 14, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 37 |
| CEO | Dagi Ben-Noon |
Contact Details
Address: 2 Ha-Tidhar St. Ra'anana, 4366504 Israel | |
| Phone | 972 4 623 0333 |
| Website | inspira-technologies.com |
Stock Details
| Ticker Symbol | IINN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.51 |
| CIK Code | 1837493 |
| CUSIP Number | M53637100 |
| ISIN Number | IL0011715781 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer and Director |
| Yafit Tehila | Chief Financial Officer |
| Avi Shabtai | Chief Operating Officer and Vice President of Research and Development |
| Sivan Ozeri | Administrative Manager |
| Adi Shmueli | Director of Marketing |
| Mike Hershkovitz | Vice President of Global Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 6, 2026 | 6-K | Report of foreign issuer |
| Apr 6, 2026 | 6-K | Report of foreign issuer |
| Mar 31, 2026 | 6-K | Report of foreign issuer |
| Mar 26, 2026 | 6-K | Report of foreign issuer |
| Mar 26, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Mar 26, 2026 | 6-K | Report of foreign issuer |
| Mar 5, 2026 | SCHEDULE 13G/A | Filing |
| Feb 25, 2026 | 6-K | Report of foreign issuer |
| Feb 18, 2026 | 6-K | Report of foreign issuer |
| Feb 18, 2026 | 6-K | Report of foreign issuer |